257 related articles for article (PubMed ID: 14645156)
1. Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice.
Levisetti MG; Suri A; Vidavsky I; Gross ML; Kanagawa O; Unanue ER
Int Immunol; 2003 Dec; 15(12):1473-83. PubMed ID: 14645156
[TBL] [Abstract][Full Text] [Related]
2. Endogenous ecotropic murine leukemia viral (MuLV) envelope protein as a new autoantigen reactive with non-obese diabetic mice sera.
Choi SE; Kim KS; Kim KH; Choi UY; Kim HM; Yoon JW; Kang Y
J Autoimmun; 2000 Nov; 15(3):347-57. PubMed ID: 11040075
[TBL] [Abstract][Full Text] [Related]
3. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
4. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
5. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
6. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
7. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
10. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.
Walter U; Toepfer T; Dittmar KE; Kretschmer K; Lauber J; Weiss S; Servos G; Lechner O; Scherbaum WA; Bornstein SR; Von Boehmer H; Buer J
Diabetologia; 2003 Aug; 46(8):1106-14. PubMed ID: 12856083
[TBL] [Abstract][Full Text] [Related]
12. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against pancreatic beta-cells: characterization by western blot analysis in the non-obese diabetic (NOD) mouse.
Villà MC; Bécourt C; Gia HP; Sempé P; Portier MM; Bach JF; Boitard C
J Autoimmun; 1992 Feb; 5(1):47-58. PubMed ID: 1558639
[TBL] [Abstract][Full Text] [Related]
14. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
[TBL] [Abstract][Full Text] [Related]
15. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.
Calderon B; Carrero JA; Miller MJ; Unanue ER
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1561-6. PubMed ID: 21220322
[TBL] [Abstract][Full Text] [Related]
17. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
[TBL] [Abstract][Full Text] [Related]
18. Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products.
Boitard C; Villa MC; Becourt C; Gia HP; Huc C; Sempe P; Portier MM; Bach JF
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):172-6. PubMed ID: 1729686
[TBL] [Abstract][Full Text] [Related]
19. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
Judkowski V; Pinilla C; Schroder K; Tucker L; Sarvetnick N; Wilson DB
J Immunol; 2001 Jan; 166(2):908-17. PubMed ID: 11145667
[TBL] [Abstract][Full Text] [Related]
20. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]